Cytochrome P450 Oxidoreductase Deficiency: Identification and Characterization of Biallelic Mutations and Genotype-Phenotype Correlations in 35 Japanese Patients
The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
CONTEXT: Cytochrome P450 oxidoreductase (POR) deficiency is a rare autosomal recessive disorder characterized by skeletal dysplasia, adrenal dysfunction, disorders of sex development (DSD), and maternal virilization during pregnancy. Although multiple studies have been performed for this condition, several matters remain to be clarified, including the presence of manifesting heterozygosity and the underlying factors for clinical variability. OBJECTIVE: The objective of the study was to examine such unresolved matters by detailed molecular studies and genotype-phenotype correlations. PATIENTS: Thirty-five Japanese patients with POR deficiency participated in the study. RESULTS: Mutation analysis revealed homozygosity for R457H in cases 1-14 (group A), compound heterozygosity for R457H and one apparently null mutation in cases 15-28 (group B), and other combinations of mutations in cases 29-35 (group C). In particular, FISH and RT-PCR sequencing analyses revealed an intragenic microdeletion in one apparent R457H homozygote, transcription failure of apparently normal alleles in three R457H heterozygotes, and nonsense mediated mRNA decay in two frameshift mutation-positive cases examined. Genotype-phenotype correlations indicated that skeletal features were definitely more severe, and adrenal dysfunction, 46,XY DSD, and pubertal failure were somewhat more severe in group B than group A, whereas 46,XX DSD and maternal virilization during pregnancy were similar between two groups. Notable findings also included the contrast between infrequent occurrence of 46,XY DSD and invariable occurrence of 46,XX DSD and pubertal growth pattern in group A mimicking that of aromatase deficiency. CONCLUSIONS: The results argue against the heterozygote manifestation and suggest that the residual POR activity reflected by the R457H dosage constitutes the underlying factor for clinical variability in some features but not other features, probably due to the simplicity and complexity of POR-dependent metabolic pathways relevant to each phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in POR can lead to Cytochrome P450 oxidoreductase deficiency (PORD; OMIM 613,571 and 201750), a rare form of congenital adrenal hyperplasia, disrupting the steroid production in the adrenal and gonads [2,9].”
From Loss of Protein Stability and Function Caused by P228L Variation in NADPH-Cytochrome P450 Reductase Linked to Lower Testosterone Levels (2022) · cites this paper as [9]
In the citing paper
“Using MLPA, we were able to identify a partial deletion (exons U1–1), also previously described elsewhere (14), and for the first time a partial duplication (exons 2–5) of the POR gene on alleles with no mutation detected by direct sequencing.”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [14]
In the citing paper
“PORD manifests with a wide range of clinical signs and symptoms, and our study shows a broader phenotypic expression in Caucasian patients than previously observed in a large Japanese cohort (3, 7, 14, 15).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [14]
In the citing paper
“The Japanese data suggest that p.R457H might be associated with virilization in 46,XX patients but most likely results in normal male genital development (14).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [14]
In the citing paper
“However, apart from a large Japanese series of patients mainly carrying the p.R457H mutation in homozygous or compound heterozygous state (14), no report on a clinically well-characterized PORD patient cohort has addressed this important clinical issue systematically.”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [14]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530621 · Cited by 1,416
Effect of testosterone and estradiol in a man with aromatase deficiency
Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K. S., & Simpson, E. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370204 · Cited by 1,151 · cited 1×
“pattern of cases 2 and 3 without scoliosis is considered to represent a mild form of that of male patients with aromatase deficiency (28, 29).”
BackgroundMutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509 · cited 3×
“Because the microdeletion was found in case 21 with apparent R457H homozygosity, such a microdeletion might be hidden in the previously reported patients with apparent homozygosity (1, 5).”
BackgroundSelf-citationPosition effect in human genetic disease
Kleinjan, D. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.10.1611 · Cited by 370
The backdoor pathway to dihydrotestosterone
Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347 · cited 1×
“the fetal testis, backdoor pathway, and placenta (3, 4, 9, 25, 26) (Fig.”
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345 · cited 1×
“In this regard, A287P is common in Caucasian patients (4, 5), and clinical studies in 10 A287Ppositive patients including three homozygotes (five with 46,XY and five with 46,XX) have suggested phenotypic similarities and differences between R457H-positive patients and A287P-positive patients: 1) skeletal phenotype is…”
BackgroundHuang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
Carter, M. S., Doskow, J., Morris, P., Li, S., Nhim, R. P., Sandstedt, S., & Wilkinson, M. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28995 · Cited by 329
Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges
Kuzmiak, H. A., & Maquat, L. E. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.05.005 · Cited by 253
Research works printed but not linked: 2
- Yokoya, 1983, Penile and clitoral sizes in premature newborns, full term neonates, infants, and children, Horumon to Rinsho, 31, 1215
- Hasegawa, 2003, Normal range of GnRH and hCG stimulation tests. In: Let’s enjoy pediatric endocrinology
Cited by
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Malformation syndromes caused by disorders of cholesterol synthesis
Porter, F. D., & Herman, G. E. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009548 · Cited by 473
NADPH P450 oxidoreductase: Structure, function, and pathology of diseases
Pandey, A. V., & Flück, C. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.010 · Cited by 279
A Genetic-Pathophysiological Framework for Craniosynostosis
Twigg, S. R. F., & Wilkie, A. O. M. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.07.006 · Cited by 276
“A genotype-phenotype correlation is apparent, such that individuals with skeletal malformations are usually compound heterozygous for variants encoding a combination of a missense and a null allele; moreover, no subjects harboring homozygous null mutations have been encountered, supporting the conclusion from mouse st…”
BackgroundFlück, C. E., Meyer-Böni, M., Pandey, A. V., Kempná, P., Miller, W. L., Schoenle, E. J., & Biason-Lauber, A. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.009 · Cited by 248
NADPH–Cytochrome P450 Oxidoreductase: Roles in Physiology, Pharmacology, and Toxicology
Riddick, D. S., Ding, X., Wolf, C. R., Porter, T. D., Pandey, A. V., Zhang, Q., Gu, J., Finn, R. D., Ronseaux, S., McLaughlin, L. A., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.048991 · Cited by 164
Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency
Krone, N., Reisch, N., Idkowiak, J., Dhir, V., Ivison, H. E., Hughes, B. A., Rose, I. T., O'Neil, D. M., Vijzelaar, R., Smith, M. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0640 · Cited by 163
Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
Storbeck, K.-H., Schiffer, L., Baranowski, E. S., Chortis, V., Prete, A., Barnard, L., Gilligan, L. C., Taylor, A. E., Idkowiak, J., Arlt, W., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00262 · Cited by 141
Aromatase deficiency in men: a clinical perspective
Rochira, V., & Carani, C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.176 · Cited by 134
Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency
Xia, C., Panda, S. P., Marohnic, C. C., Martásek, P., Masters, B. S., & Kim, J.-J. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106632108 · Cited by 115
Fukami, M., Homma, K., Hasegawa, T., & Ogata, T. (2013) · Developmental Dynamics · doi:10.1002/dvdy.23892 · Cited by 114
“OH progesterone levels are usually higher in 21- OHD than in PORD (Fukami et al., 2006, 2009; Conte and Grumbach, 2011; Stewart and Krone, 2011), and the 17/20 lyase activity of CYP17A1, though it is physiologically low for 17-”
BackgroundSelf-citationAgrawal, V., Choi, J. H., Giacomini, K. M., & Miller, W. L. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833e0cb5 · Cited by 104
Clinical, genetic and enzymatic characterization of P450 oxidoreductase deficiency in four patients
Sahakitrungruang, T., Huang, N., Tee, M. K., Agrawal, V., Russell, W. E., Crock, P., Murphy, N., Migeon, C. J., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1460 · Cited by 82
P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms
Burkhard, F. Z., Parween, S., Udhane, S. S., Flück, C. E., & Pandey, A. V. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.04.003 · Cited by 79
Monogenic disorders of adrenal steroidogenesis
Baranowski, E. S., Arlt, W., & Idkowiak, J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488034 · Cited by 79
Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency
Reisch, N., Idkowiak, J., Hughes, B. A., Ivison, H. E., Abdul-Rahman, O. A., Hendon, L. G., Olney, A. H., Nielsen, S., Harrison, R., Blair, E. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3449 · Cited by 67
46,XX DSD: the masculinised female
Auchus, R. J., & Chang, A. Y. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.11.001 · Cited by 67
Idkowiak, J., O'Riordan, S., Reisch, N., Malunowicz, E. M., Collins, F., Kerstens, M. N., Köhler, B., Graul-Neumann, L. M., Szarras-Czapnik, M., Dattani, M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1607 · Cited by 64
Stewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Baronio, F., Ortolano, R., Menabò, S., Cassio, A., Baldazzi, L., Natale, V. D., Tonti, G., Vestrucci, B., & Balsamo, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184605 · Cited by 60
Classic congenital adrenal hyperplasia and its impact on reproduction
Gomes, L. G., Bachega, T. A. S. S., & Mendonca, B. B. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.037 · Cited by 58
Fukami, M., & Ogata, T. (2014) · Pediatrics International · doi:10.1111/ped.12518 · Cited by 56
Self-citationDhir, V., Reisch, N., Bleicken, C., Lebl, J., Kamrath, C., Schwarz, H., Grötzinger, J., Sippell, W. G., Riepe, F. G., Arlt, W., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0172 · Cited by 52
Clinical and Biochemical Consequences of P450 Oxidoreductase Deficiency
Flück, C. E., & Pandey, A. V. (2011) · Endocrine Development · doi:10.1159/000321221 · Cited by 52
Restoration of mutant cytochrome P450 reductase activity by external flavin
Nicolo, C., Flück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.024 · Cited by 51
Fertility Issues in Disorders of Sex Development
Guercio, G., Costanzo, M., Grinspon, R. P., & Rey, R. A. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.07.012 · Cited by 46
Yazawa, T., Imamichi, Y., Sekiguchi, T., Miyamoto, K., Uwada, J., Khan, M. R. I., Suzuki, N., Umezawa, A., & Taniguchi, T. (2019) · BioMed Research International · doi:10.1155/2019/8973076 · Cited by 44
Dean, B., Chrisp, G. L., Quartararo, M., Maguire, A. M., Hameed, S., King, B. R., Munns, C. F., Torpy, D. J., Falhammar, H., & Rushworth, R. L. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz255 · Cited by 43
Classic and backdoor pathways of androgen biosynthesis in human sexual development
Lee, H. G., & Kim, C. J. (2022) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2244124.062 · Cited by 42
Achermann, J. C., & Hughes, I. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00023-7 · Cited by 41
Novel Insight into Etiology, Diagnosis and Management of Primary Adrenal Insufficiency
Malikova, J., & Flück, C. E. (2014) · Hormone Research in Paediatrics · doi:10.1159/000363107 · Cited by 40
Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
Ishii, T., Anzo, M., Adachi, M., Onigata, K., Kusuda, S., Nagasaki, K., Harada, S., Horikawa, R., Minagawa, M., Minamitani, K., et al. (2015) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.24.77 · Cited by 44
Self-citationPapadakis, G. E., Dumont, A., Bouligand, J., Chasseloup, F., Raggi, A., Catteau-Jonard, S., Boute‐Bénéjean, O., Pitteloud, N., Young, J., & Dewailly, D. (2020) · Human Reproduction · doi:10.1093/humrep/deaa020 · Cited by 38
Parween, S., Roucher-Boulez, F., Flück, C. E., Lienhardt-Roussie, A., Mallet, D., Morel, Y., & Pandey, A. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1928 · Cited by 37
Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)
Ishii, T., Kashimada, K., Amano, N., Takasawa, K., Nakamura‐Utsunomiya, A., Yatsuga, S., Mukai, T., Ida, S., Isobe, M., Fukushi, M., et al. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0009 · Cited by 37
Self-citationLi, H., Zhao, A., Xie, M., Chen, L., Wu, H., Shen, Y., & Wang, H. (2021) · Translational Pediatrics · doi:10.21037/tp-21-499 · Cited by 36
Janner, M., Flück, C. E., & Mullis, P. E. (2012) · Hormone Research in Paediatrics · doi:10.1159/000341585 · Cited by 36
Consanguinity and Disorders of Sex Development
Bashamboo, A., & McElreavey, K. (2014) · Human Heredity · doi:10.1159/000360763 · Cited by 36
Bai, Y., Li, J., & Wang, X. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0312-9 · Cited by 34
Stewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 35
Cytochrome P450 Oxidoreductase Deficiency
Idkowiak, J., Cragun, D. L., Hopkin, R. J., & Arlt, W. (2009) · University of Washington, Seattle eBooks · Cited by 33
Diagnosis of Diseases of Steroid Hormone Production, Metabolism and Action
Honour, J. W. (2009) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.v1i5.209 · Cited by 32
Modeling of human P450 oxidoreductase structure by in silico mutagenesis and MD simulation
Flück, C. E., Mullis, P. E., & Pandey, A. V. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.001 · Cited by 32
Koyama, Y., Homma, K., Fukami, M., Miwa, M., Ikeda, K., Ogata, T., Hasegawa, T., & Murata, M. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.173286 · Cited by 30
Self-citationFukami, M., Nagai, T., Mochizuki, H., Muroya, K., Yamada, G., Takitani, K., & Ogata, T. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.03.023 · Cited by 30
Self-citationClinical and molecular review of atypical congenital adrenal hyperplasia
Sahakitrungruang, T. (2015) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2015.20.1.1 · Cited by 30
Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant
Balsamo, A., Baronio, F., Ortolano, R., Menabò, S., Baldazzi, L., Natale, V. D., Vissani, S., & Cassio, A. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.593315 · Cited by 30
Pediatric Disorders of Sex Development
Achermann, J. C., & Hughes, I. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00023-x · Cited by 29
Parween, S., Fernández-Cancio, M., Benito-Sanz, S., Camats, N., Rojas Velazquez, M. N., López-Siguero, J.-P., Udhane, S. S., Kagawa, N., Flück, C. E., Audí, L., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa076 · Cited by 28
Rare forms of congenital adrenal hyperplasia
Tosun, B. G., & Güran, T. (2023) · Clinical Endocrinology · doi:10.1111/cen.15009 · Cited by 28
Pan, P., Zheng, L., Chen, X., Huang, J., Yang, D., & Li, Y. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00778-0 · Cited by 27
Song, T., Wang, B., Chen, H., Zhu, J., & Sun, H. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1393663 · Cited by 24
Hughes, I. A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.03.005 · Cited by 24
Soneda, S., Yazawa, T., Fukami, M., Adachi, M., Mizota, M., Fujieda, K., Miyamoto, K., & Ogata, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1337 · Cited by 23
Self-citationFan, L., Ren, X., Song, Y., Su, C., Fu, J., & Gong, C. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1283-2 · Cited by 22
Gusmano, C., Cannarella, R., Crafa, A., Barbagallo, F., Vignera, S. L., Condorelli, R. A., & Calogero, A. E. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01849-9 · Cited by 21
Arboleda, V. A., Fleming, A. A., & Vilain, E. J. N. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374430-2.00021-3 · Cited by 20
Bonamichi, B. D. S. F., Santiago, S. L. M., Bertola, D. R., Kim, C. A., Alonso, N., Mendonca, B. B., Bachega, T. A. S. S., & Gomes, L. G. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000213 · Cited by 19
“2016;60/5 genitalia in both 46,XX than 46,XY patients (100% versus 44%, respectively) (13).”
BackgroundDifferentiation of mesenchymal stem cells into gonad and adrenal steroidogenic cells
Yazawa, T., Imamichi, Y., Miyamoto, K., Umezawa, A., & Taniguchi, T. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i2.203 · Cited by 18
Lee, Y., Choi, J.-H., Oh, A., Kim, G.-H., Park, S.-H., Moon, J. E., Ko, C. W., Cheon, C.-K., & Yoo, H.-W. (2020) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.1938152.076 · Cited by 16
Tzetis, M., Konstantinidou, A. E., Sofocleous, C., Kosma, K., Mitrakos, A. K., Tzannatos, C. A., & Kitsiou‐Tzeli, S. (2016) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23492 · Cited by 16
Delayed diagnosis of disorder of sex development (DSD) due to P450 oxidoreductase (POR) deficiency
Koika, V., Armeni, A. K., & Georgopoulos, N. A. (2016) · HORMONES · doi:10.14310/horm.2002.1679 · Cited by 14
Koyama, Y., Homma, K., Fukami, M., Miwa, M., Ikeda, K., Ogata, T., Murata, M., & Hasegawa, T. (2016) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.25.37 · Cited by 13
Self-citationVelazquez, M. N. R., Therkelsen, S., & Pandey, A. V. (2023) · Biomolecules · doi:10.3390/biom13121728 · Cited by 13
Sánchez-Garvín, D., Albaladejo, S., Ezquieta, B., & Corripio, R. (2013) · BMJ Case Reports · doi:10.1136/bcr-2013-010251 · Cited by 13
P450 oxidoreductase deficiency with maternal virilization during pregnancy
Nakanishi, K., Yamashita, A., Miyamoto, T., Takeguch, R., Furuya, A., Matsuo, K., Tanahashi, Y., Kawamura, M., & Sengoku, K. (2016) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog3172.2016 · Cited by 13
Unal, E., Demiral, M., Yıldırım, R., Taş, F. F., Ceylaner, S., & Özbek, M. N. (2021) · Hormones · doi:10.1007/s42000-020-00249-z · Cited by 12
Human P450 Oxidoreductase Deficiency
Flück, C. E., & Pandey, A. V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64966-8 · Cited by 12
Acharya, K. S., Schrott, R., Grenier, C., Huang, Z., Holloway, Z., Hawkey, A. B., Levin, E. D., & Murphy, S. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-69204-7 · Cited by 12
Rojas Velazquez, M. N., Noebauer, M., & Pandey, A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710141 · Cited by 11
Wang, C., & Tian, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1226387 · Cited by 11
P450 Oxidoreductase Deficiency (PORD)
Flück, C. E., & Pandey, A. V. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00010-7 · Cited by 11
Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
Zhang, J., Woo, K. L., Hai, Y., Wang, S., Lin, Y., Huang, Y., Peng, X., Wu, H., Zhang, S., Yan, L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1020880 · Cited by 10
Albrecht, E. D., Aberdeen, G. W., Babischkin, J. S., Prior, S. J., Lynch, T. J., Baranyk, I. A., & Pepe, G. J. (2022) · Endocrinology · doi:10.1210/endocr/bqac037 · Cited by 10
Clinical characteristics of cytochrome P450 oxidoreductase deficiency: a nationwide survey in Japan
Yatsuga, S., Amano, N., Nakamura-Utsunomiya, A., Kobayashi, H., Takasawa, K., Nagasaki, K., Nakamura, A., Nishigaki, S., Numakura, C., Fujiwara, I., et al. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0011 · Cited by 9
“The male:female ratio among patients with PORD is reportedly close to 1:1 [4], which is similar to our results.”
BackgroundResultSelf-citationLi, Y., Zhang, C., & Zhang, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1019696 · Cited by 9
Two cases of cytochrome P450 oxidoreductase deficiency with severe scoliosis and surgery requirement
Onuki, T., Ohtsu, Y., Hiroshima, S., Sawano, K., & Nagasaki, K. (2021) · Congenital Anomalies · doi:10.1111/cga.12434 · Cited by 9
Ono, H., Numakura, C., Homma, K., Hasegawa, T., Tsutsumi, S., Kato, F., Fujisawa, Y., Fukami, M., & Ogata, T. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.12.008 · Cited by 9
Self-citationEstrogen stimulates fetal vascular endothelial growth factor expression and microvascularization
Aberdeen, G. W., Babischkin, J. S., Pepe, G. J., & Albrecht, E. D. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0364 · Cited by 9
Congenital Adrenal Hyperplasia
Trapp, C. M., Levine, L. S., & Oberfield, S. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_14 · Cited by 8
In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase
Nurhafizuddin, M., Azizi, A., Ming, L. C., & Shafqat, N. (2022) · Molecules · doi:10.3390/molecules27144646 · Cited by 8
Arboleda, V. A., & Vilain, E. J. N. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00017-2 · Cited by 6
Disorders of sterol biosynthesis
Furtado, L. V., Kelley, R. I., & Opitz, J. M. (2016) · Translational Science of Rare Diseases · doi:10.3233/trd-160004 · Cited by 6
Prenatal Diagnosis - Morphology Scan and Invasive Methods
Choy, R. K. W., & Leung, T. Y. (2012) · InTech eBooks · doi:10.5772/1283 · Cited by 6
Pathophysiology of estrogen action in men
Rochira, V., Santi, D., & Carani, C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.020 · Cited by 5
SATO, T. A., Ishii, T., Fukami, M., Ogata, T., & Hasegawa, T. (2022) · Congenital Anomalies · doi:10.1111/cga.12464 · Cited by 5
Self-citationDélot, E. C., & Vilain, E. J. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00016-0 · Cited by 5
Zhang, D., 姚凤霞, Luo, M., Deng, S., & Tian, Q. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01878-8 · Cited by 5
Flück, C. E. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8002-1_1 · Cited by 5
P450 oxidoreductase deficiency
Flück, C. E., Velazquez, M. N. R., & Pandey, A. V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00012-5 · Cited by 4
Aromatase Deficiency and Aromatase Excess
Russell, J. F., Wong, J. C., & Grumbach, M. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00012-0 · Cited by 4
Congenital Adrenal Hyperplasia (CAH): Definition and Enzymatic Defects in Various Forms
Keleştimur, F., & Ünlühızarcı, K. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_1 · Cited by 4
Velazquez, M. N. R., Noebauer, M., & Pandey, A. V. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.16.504152 · Cited by 4
[Audiological phenotypes of Antlet-Bixler syndrome: a case report and literatures review].
Zhao, M., Zhang, J., & Wang, Q. (2023) · PubMed Central · doi:10.13201/j.issn.2096-7993.2023.03.016 · Cited by 3
Niwa, T., Minami, K., & Katagiri, M. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-nt-102 · Cited by 3
Congenital adrenal hyperplasia
Krone, N. P. (2011) · doi:10.1093/med/9780199235292.003.0616 · Cited by 3
Molecular diagnosis of two families with classic congenital adrenal hyperplasia
Tian, J., Yang, G., Wang, S., Zhang, Y., Song, G., & Zheng, F. (2011) · Gene · doi:10.1016/j.gene.2011.05.019 · Cited by 3
Anaforoğlu, İ. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_5 · Cited by 1
Tian, Y., Pei, Y., Fang, Y., Yang, X., & Liang, Y. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s580471 · Cited by 1
Disorders of Adrenal Steroid Biosynthesis Defects
He, X., & Auchus, R. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822563-9.00216-x · Cited by 1
Metadata
- Authors
- Fukami, M., Nishimura, G., Homma, K., Nagai, T., Hanaki, K., Uematsu, A., Ishii, T., Numakura, C., Sawada, H., Nakacho, M., Kowase, T., Motomura, K., Haruna, H., Nakamura, M., Ohishi, A., Adachi, M., Tajima, T., Hasegawa, Y., Hasegawa, T., Horikawa, R., Fujieda, K., & Ogata, T.
- Affiliations
- National Center For Child Health and Development (JP)
- Tokyo Metropolitan Kiyose Children's Hospital (JP)
- Keio University Hospital (JP)
- Dokkyo Medical University Saitama Medical Center (JP)
- Tottori University Hospital (JP)
- Shizuoka Children's Hospital (JP)
- Yamagata University Hospital (JP)
- University of Miyazaki Hospital (JP)
- Osaka Women's and Children's Hospital (JP)
- Gunma University Hospital (JP)
- Nagasaki University Hospital (JP)
- Juntendo University Hospital (JP)
- Kagoshima University Hospital (JP)
- Hamamatsu University Hospital (JP)
- Kanagawa Children's Medical Center (JP)
- Hokkaido University (JP)
- Asahikawa Medical College Hospital (JP)
- Corresponding author
- Fukami, Maki
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-05-01
- Volume
- 94
- Issue
- 5
- Pages
- 1723-1731
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1990664334
- Cited by
- 117
- References
- 37
- Citations by year
- 2026: 7 · 2025: 2 · 2024: 3 · 2023: 6 · 2022: 11 · 2021: 7 · 2020: 9 · 2019: 8 · 2018: 3 · 2017: 3 · 2016: 10 · 2015: 5 · 2014: 4 · 2013: 7 · 2012: 7
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- POR, compound heterozygosity, genotype-phenotype correlation, autosomal recessive disorder, skeletal dysplasia, adrenal insufficiency, disorders of sex development, 46,XX disorders of sex development, 46,XY disorders of sex development, pubertal failure, nonsense-mediated mRNA decay, Japanese patients
- MeSH terms
- Adolescent, Adrenal Cortex Hormones, Alleles, Bone Diseases, Child, Child, Preschool, Cytochrome P-450 Enzyme System, Exons, Female, Genotype, Heterozygote, Homozygote, Humans, Infant, Japan, Male, Mutation, Oxidoreductases, Phenotype, Sexual Maturation, Genetic Variation, In Situ Hybridization, Fluorescence, Gene Dosage, Reverse Transcriptase Polymerase Chain Reaction, Cell Line, Tumor, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.